Tdap, MenACWY coverage increased in teens from 2023 to 2024

From 2023 to 2024, coverage with one or more doses of the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) and the quadrivalent meningococcal conjugate vaccine (MenACWY) increased, while human papillomavirus (HPV) vaccination coverage remained stable, according to research published in the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup